Typhim Vi Interactions
There are 298 drugs known to interact with Typhim Vi (typhoid vaccine, inactivated), along with 4 disease interactions. Of the total drug interactions, 1 is major, 295 are moderate, and 2 are minor.
- View all 298 medications that may interact with Typhim Vi
- View Typhim Vi disease interactions (4)
Most frequently checked interactions
View interaction reports for Typhim Vi (typhoid vaccine, inactivated) and the medicines listed below.
- acetaminophen
- acetazolamide
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- amoxicillin
- aspirin
- atorvastatin
- Boostrix (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- brimonidine / timolol ophthalmic
- cyclobenzaprine
- dorzolamide ophthalmic
- doxycycline
- EpiPen (epinephrine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Havrix (hepatitis a adult vaccine)
- hydroxyzine
- loperamide
- Lumigan (bimatoprost ophthalmic)
- Malarone (atovaquone / proguanil)
- meloxicam
- multivitamin with minerals
- omeprazole
- prednisone
- Rhopressa (netarsudil ophthalmic)
- Rocklatan (latanoprost / netarsudil ophthalmic)
- tramadol
- Twinrix (hepatitis a adult vaccine / hepatitis b adult vaccine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Typhim Vi disease interactions
There are 4 disease interactions with Typhim Vi (typhoid vaccine, inactivated) which include:
Report options
QR code containing a link to this page
More about Typhim Vi (typhoid vaccine, inactivated)
- Typhim Vi consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: bacterial vaccines
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.